Glycemic control in end stage kidney disease patients who on automated peritoneal dialysis end stage kidney disease, automated peritoneal dialysis, peritoneal dialysis, continuous glucose monitoring, glycemic profile, time in range, diabetes mellitus
Conditions
Interventions
Automated peritoneal dialysis patients, who have diabetes mellitus that using insulin therapy,Automated peritoneal dialysis patients, who have diabetes mellitus without using insulin therapy,Automate
Treatment,Treatment,Treatment
DM with insulin group,DM without insulin group,nondiabetic patient group
Sponsors
Routine to Research, Faculty of medicine, Siriraj hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1.End stage renal disease on automated peritoneal dialysis patients, which initiated more than 1 month and performed peritoneal equilibration test within 6 months 2.Age >/= 18 year 3.Accepted in CGM and can perform self-monitoring blood glucose
Exclusion criteria
Exclusion criteria: 1. Need to change regimen in automated peritoneal dialysis within 7 days 2. Hospitalized or diagnosed peritonitis within 4 weeks
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| glycemic profiles (time in range, mean 24 hr. glucose, peak of glucose) 7 days interstitial glucose by cgm (mg/dl) | — |
Secondary
| Measure | Time frame |
|---|---|
| glycemic profiles (time in range, mean 24 hr. glucose, peak of glucose) between membrane transport groups, insulin regimens 7 days interstitial glucose by cgm (mg/dl) | — |
Countries
Thailand
Contacts
Public ContactThatsaphan Srithongkul
Faculty of medicine, Siriraj hospital, Mahidol university
Outcome results
None listed